Kawasaki Disease
Stable Kawasaki disease incidence during COVID-19 quarantine suggests airborne transmission
Despite COVID-19 quarantine measures, Kawasaki disease incidence was unchanged in Japan compared with significant declines in respiratory tract and gastrointestinal infections, indicating airborne rather than contact or droplet transmission.
COVID-19 positivity, myocarditis distinguish MIS-C from Kawasaki disease
COVID-19 positivity, older age at onset, and the presence of myocarditis are more common with multisystemic inflammatory syndrome in children than with Kawasaki disease, according to data published Pediatric Rheumatology.
MIS-C mystery persists even as rheumatologists' arsenal proves key to treatment
As physicians around the world scrambled throughout early 2020 to respond to the exploding COVID-19 pandemic, the one promising development appeared to be that children were at relatively low risk compared with adults.
Q&A: Inflammatory response to COVID-19 infection in children may affect CV, other systems
Hospitals in the U.S. and the CDC have reported rising incidence of multisystem inflammatory syndrome in children after COVID-19 infection.
Long-term CVD monitoring needed for children with Kawasaki disease
The risk for cardiovascular disease persists for 10 years after initial hospitalization among children with Kawasaki disease, according to data presented at the ACR Convergence 2020 virtual meeting.
Top in cardiology: Sleep apnea and AF, Kawasaki disease
Researchers reported that sleep apnea is often undiagnosed in patients with atrial fibrillation despite its prevalence in this patient population. It was the top story in cardiology last week.
Combination therapy reduces risk for abnormalities, treatment failure in Kawasaki disease
Corticosteroids with standard treatment for patients with Kawasaki disease reduced the risk for coronary artery abnormalities and treatment failure, researchers found.
AAP issues guidance on multisystem inflammatory syndrome in children
The AAP has developed guidance on identifying, testing and treating children with multisystem inflammatory syndrome, which has been associated with COVID-19.
ACR unveils guidance for multisystem inflammatory syndrome in children with COVID-19
Multisystem inflammatory syndrome in children associated with COVID-19 may share overlapping clinical features with Kawasaki Disease unrelated to the pandemic, according to guidelines released by the American College of Rheumatology.
‘This is something new’: Syndrome associated with COVID-19 sickens more kids
As of Thursday, New York said it was investigating 110 cases and three deaths among children experiencing a syndrome that has features similar to atypical Kawasaki disease and toxic shock syndrome. New York Governor Andrew M. Cuomo has said that 60% of children with the syndrome tested positive for SARS-CoV-2 infection, and the other 40% had antibodies specific to the coronavirus, which causes COVID-19.